Ribociclib
Drug timelines are a Plus or Pro feature.
53 regulatory and trial events tracked for Ribociclib, covering 2019-10-18 to 2026-07-10. Get the full timeline:
Most recent: Clinical Trial Results: Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant [Phase 3]